QYResearch QYResearch focus on Market Survey and Research
www.qyresearchglobal.com
Beijing Hengzhou Bozhi International Information Consulting Web: qyresearchglobal.com | qyresearcheurope.com | qyresearch.com | qyresearch.com/english | qyresearchjapan.com TEL: +86-13660489419, Office: +86-2086655165 Media: press@qyresearch.com Marketing: sales@qyresearch.com Facebook: @QYResearchOfficial, Twitter: @QYResearch_ Wechat Official Account: QYResearch, Weibo: 恒州博智
www.qyresearchglobal.com
QYResearch
Hydroxyapatite-coated Femoral Components refers to a hard tissue implant material coated with hydroxyapatite on femur components using titanium as a base and physically and chemically. After the material is implanted into the human body, the titanium alloy can provide sufficient mechanical strength, the surface of the hydroxyapatite coating is easy to combine with the human bone, in the human bone surface induced new bone formation, generally months to induce new bone formation.
www.qyresearchglobal.com
QYResearch In the last several years, global market of hydroxyapatite-coated femoral components developed rapidly, with an average growth rate of 6.52%. In 2015, global revenue of hydroxyapatite-coated femoral components is nearly 985.5 M USD; the actual production is about 737.4 K Unit. According to QYResearch, The global average price of hydroxyapatite-coated femoral components is in the decreasing trend, from 1375 USD/Unit in 2011 to 1336 USD/Unit in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years. The classification of hydroxyapatite-coated femoral components includes primary, and revision. The proportion of primary in 2015 is about 65.5%, and the proportion is in increasing trend from 2011 to 2015. www.qyresearchglobal.com
QYResearch Hydroxyapatite-coated femoral components are widely used in hospital and clinic. The most proportion of hydroxyapatite-coated femoral components is hospital, and the sales volume in 2015 is 528.8 K Unit. The trend of hospital is increasing. North America region is the largest supplier of hydroxyapatite-coated femoral components, with a production market share nearly 65% in 2015. Europe is the second largest supplier of hydroxyapatite-coated femoral components, enjoying production market share about 17% in 2015. North America is the largest consumption place, with a consumption market share nearly 36% in 2015. Following USA, Europe is the second largest consumption place with the consumption market share of 20%.
www.qyresearchglobal.com
QYResearch PART 1 请输入你的标题 Market competition is not intense. Zimmer Biomet, Stryker, Nano Interface Technology, DePuy, Synthes, Smith & Nephew, etc. are the leaders of the industry, and they hold key technologies and patents, with highend customers; have been formed in the monopoly position in the industry.
Full Report Link: http://www.qyresearchglobal.com/goods-1135259.html www.qyresearchglobal.com